The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck

被引:23
|
作者
Daly, T
Poulsen, MG
Denham, JW
Peters, LJ
Lamb, DS
Krawitz, H
Hamilton, C
Keller, J
Tripcony, L
Walker, Q
机构
[1] Univ Queensland, Royal Brisbane Hosp, Div Oncol Incorporating Queensland Radium Inst, Herston, Qld 4029, Australia
[2] Mater Misericordiae Hosp, Dept Radiat Oncol, Newcastle, NSW 2310, Australia
[3] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
[4] Wellington Hosp, Wellington Canc Ctr, Wellington, New Zealand
[5] Auckland Hosp, Auckland, New Zealand
关键词
anemia; radiotherapy toxicity; head and neck carcinoma; squamous cell carcinoma; post radiotherapy survival;
D O I
10.1016/S0167-8140(03)00198-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aims of this analysis were to determine the effect of anaemia on loco-regional control, relapse-free survival, cause-specific survival, overall Survival, and acute and late radiation therapy toxicity in patients with Stage III and IV squamous cell carcinoma of the head and neck treated with radiotherapy. Patients and methods: Between 1991 and 1998, 350 patients were randomly assigned to either conventional radiotherapy, (70 Gy in 35 fractions in 49 days) or to accelerated radiotherapy (59.4 Gy in 33 fractions in 24 days). Patients were divided into two groups according to their haemoglobin level: a normal haemoglobin group (greater than or equal to 13 g/dl in males, greater than or equal to 12 g/dl in females) and a low haemoglobin group (< 13 g/dl in males, < 12 g/dl in females). The influence of anaemia on cause-specific Survival and the development of confluent mucositis independent of other variables was tested using Cox proportional hazards model. Results: Of 350 patients recruited to the trial, 238 had haemoglobin measurements and were eligible for inclusion in this secondary analysis. One hundred and ninety-three were considered to have normal haemoglobin, and 45 patients were considered to be anaemic. There were significant differences between the groups in loco-regional control, relapse-free survival, cause-specific Survival and overall survival, with hazards ratios of 0.56 (95% confidence interval (CI) 0.34-0.94), 0.57 (95% CI 0.35-0.92), 0.49 (95% Cl 0.29-0.85) and 0.43 (95% CI 0.26-0.70) in favour of the normal haemoglobin group. Using Cox proportional hazards modelling, haemoglobin level was a significant predictor of cause-specific survival in addition to disease site, stage, and Eastern Cooperative Oncology Group status. There were no statistically significant differences between the groups in the development of acute or late reactions. Conclusion: Significant reductions in loco-regional control, disease-free survival, cause-specific Survival and overall Survival occur in the presence of anaemia. No significant differences in normal tissue toxicity have been identified in this analysis. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 50 条
  • [1] Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck
    Ko, C.
    Citrin, D.
    ORAL DISEASES, 2009, 15 (02) : 121 - 132
  • [2] Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma
    Krstevska, V.
    JOURNAL OF BUON, 2009, 14 (03): : 361 - 373
  • [3] Efficacy of Postoperative Radiotherapy Following Induction Immunochemotherapy and Surgical Resection in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Xu, Y.
    Wang, J.
    Zhang, Y.
    Wu, R.
    Chen, X.
    Huang, X.
    Wang, K.
    Qu, Y.
    Ma, Y.
    Luo, J.
    Gui, L.
    Wang, X.
    Liu, S.
    Yi, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E802 - E802
  • [4] Weekly cisplatin with radiotherapy for locally advanced head and neck squamous cell carcinoma
    Sautois, Brieuc
    Schroeder, Helene
    Martin, Marie
    Piret, Pascal
    Demez, Pierre
    Bouchain, Olivier
    Mutijima, Eugene
    Moreau, Pierre
    JOURNAL OF BUON, 2016, 21 (04): : 979 - 988
  • [5] Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
    Ali, Elsayed M.
    Abdelraheem, Ahmad G.
    HEAD & NECK ONCOLOGY, 2011, 3
  • [6] Toxicity of Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma Treatment
    Torres, S.
    Sargento, I.
    Ferreira, M.
    Oliveira, J. O. A. O.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S552 - S552
  • [7] Chemo-radiotherapy in locally advanced squamous cell carcinoma of the head and neck: Factors affecting toxicity patterns
    Rosso, M
    Benasso, M
    Rosso, R
    JOURNAL OF CHEMOTHERAPY, 2001, 13 (06) : 648 - 652
  • [8] Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck
    Griffin, S.
    Walker, S.
    Sculpher, M.
    White, S.
    Erhorn, S.
    Brent, S.
    Dyker, A.
    Ferrie, L.
    Gilfillan, C.
    Horsley, W.
    Macfarlane, K.
    Thomas, S.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [9] Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma
    Brizel, DM
    SEMINARS IN RADIATION ONCOLOGY, 1998, 8 (04) : 237 - 246
  • [10] The "quad shot" - palliative radiotherapy in locally advanced head and neck squamous cell carcinoma
    Corry, J.
    D'costa, I.
    Milner, A.
    Fawns, H.
    Porceddu, S.
    Rischin, D.
    Peters, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 303 - 303